Loading company financials…
OTC MARKETS · Media · CIK 0000846377
$0.007
0.00% · delayed ~15 min
Last price from Oct 19, 2026
$1.5M market value
From Totaligent, Inc.'s FY2025 10-K, filed Apr 3, 2026 · read the filing
Totaligent lends money and provides credit. It took in $2.2K last year, which makes it a small company. It spends more than it earns — losing about 26692 cents on every dollar of sales.
The filing does not provide enough evidence for a clear financial conclusion.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Significant financial weakness across most measures.
From Totaligent, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Revenue
$444.5K → $2.2K
Gross profit
$43.1K → $2.2K
Operating income
-$884.7K → -$455.0K
Gross margin
9.7% → 100.0%
Measured against FY2024, from the 10-K filed Apr 3, 2026
Deteriorated: -99.5%
$444.5K to $2.2KCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
How the latest move compares (quote delayed ~15 min), and what was published around it
TGNT was unchanged on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −0.47%. That is 1.1 points below its sector and in line with the market.
No filing from TGNT and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $600.0K last year, losing about 26692 cents on every dollar of sales.
No. Sales shrank 99.5% last year.
For every $1 it owes, it owns $0.09 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors. Its operating profit does not cover its interest bill — -6.94x against the interest it owes.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it lost $600.0K and generated -$265.0K of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Apr 3, 2026Filing for FY2025 | FY202410-K · Apr 3, 2026Filing for FY2024 | FY202310-K/A · Apr 7, 2025Filing for FY2023 | FY202210-K · Oct 29, 2024Filing for FY2022 | FY201610-K · Mar 28, 2017Filing for FY2016 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $2.2K | $444.5K | $731.7K | $19.5K | — | −99.5% |
| Cost of revenue | $0.00 | $401.5K | $481.3K | $46.9K | — | −100.0% |
| Gross profit | $2.2K | $43.1K | $250.3K | -$27.4K | — | −94.8% |
| Gross marginGross profit ÷ revenueWhat is this? | 100.0% | 9.7% | 34.2% | -140.4% | — | +90.3 pts |
| Selling, general and administrative | $122.9K | $128.6K | $106.6K | $113.9K | $403.6K | −4.4% |
| Operating income | -$455.0K | -$884.7K | -$354.0K | -$551.6K | -$511.6K | +48.6% |
| Operating marginOperating income ÷ revenueWhat is this? | -20239.9% | -199.0% | -48.4% | -2828.7% | — | −20040.8 pts |
| Interest expense | $65.6K | $47.2K | $35.1K | $30.6K | $4.6K | +38.8% |
| Income before tax | -$600.0K | -$947.2K | -$402.2K | -$592.1K | — | +36.7% |
| Net income | -$600.0K | -$947.2K | -$402.2K | -$592.1K | -$516.2K | +36.7% |
| Net marginNet income ÷ revenueWhat is this? | -26692.4% | -213.1% | -55.0% | -3036.3% | — | −26479.4 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-0.002809 | $-0.005478 | $-0.002326 | $-0.006248 | $-0.048 | +48.7% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Nothing recent
No insider trades, pending-sale notices or 5% stake filings from TGNT in the last few months. That is the ordinary case, not a gap.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Operating income $65.2K narrower · Profit $41.0K narrower · Earnings per share $0.00 narrower — against Q2 FY2025
Read the filingQuarterly report for Q1 FY2026
Cash -99.7% · Operating income $28.1K wider · Profit $57.4K narrower — against Q1 FY2025
Read the filingWrite down why you are following Totaligent, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Totaligent Opens Phase I Founders Pilot: Invite-Only Real-World Deployment Begins
Yahoo Finance ·
Totaligent Announces Featured Speaking Role at U.S.–Taiwan Innovation Forum, Advancing Global Biologics and Medical Tourism Collaboration
Yahoo Finance ·
Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC
Yahoo Finance ·
Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform
Yahoo Finance ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from TGNT's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Apr 3, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 2.0 | 3/8 | 10-K, filed Apr 3, 2026 |
| FY2024 | 2.0 | 3/8 | 10-K, filed Apr 7, 2025 |
| FY2023 | 4.7 | 5/8 | 10-K, filed Oct 29, 2024 |
| FY2022 | 2.0 | 1/3 | 10-K, filed Oct 29, 2024 |
| FY2016 | 2.0 | 2/6 | 10-K, filed Mar 28, 2017 |
| FY2015 | 2.0 | 3/8 | 10-K, filed Sep 17, 2015 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
3 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: -94.8%
$43.1K to $2.2KCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: $429.7K narrower
-$884.7K to -$455.0KCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +90.3 pts
9.7% to 100.0%Critical
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Deteriorated: −20040.8 pts
-199.0% to -20239.9%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −26479.3 pts
-213.1% to -26692.4%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: $0.00 narrower
-$0.01 to -$0.00Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -78.8%
$22.1K to $4.7KCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +23.5%
172.9M to 213.6MCritical
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Improved: $347.2K narrower
-$947.2K to -$600.0KSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 19, 2026 — read it.
Improved: $65.2K narrower
-$104.5K to -$39.3KCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: $41.0K narrower
-$54.8K to -$13.8KCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: $0.00 narrower
-$0.00 to -$0.00Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -98.9%
$62.6K to $665.00Critical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +81.0%
211.1M to 382.1MCritical
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 19, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: $66.8K narrower
-$106.1K to -$39.3KCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: $94.3K narrower
-$108.1K to -$13.8KCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: $0.00 narrower
-$0.00 to -$0.00Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +42.4%
$467.00 to $665.00Critical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +78.9%
213.6M to 382.1MCritical
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
Signed a material agreement
Read the filingAnnual report for FY2025
Revenue -99.5% · Operating margin −20040.8 pts · Gross profit -94.8% — against FY2024
Read the filingSigned a material agreement
Read the filingSigned a material agreement
Read the filingSigned a material agreement
Read the filingSigned a material agreement
Read the filingSigned a material agreement
Read the filingQuarterly report for Q3 FY2025
Revenue -92.5% · Operating margin −3589.1 pts · Gross profit turned positive — against Q3 FY2024
Read the filingSigned a material agreement · Sold shares outside a public offering
Read the filingQuarterly report for Q2 FY2025
Revenue turned negative · Gross profit turned negative · Profit $69.0K narrower — against Q2 FY2024
Read the filingQuarterly report for Q1 FY2025
Revenue turned negative · Gross profit turned negative · Operating income $76.8K narrower — against Q1 FY2025
Read the filingQuarterly report for Q1 FY2025
Revenue turned negative · Gross profit turned negative · Operating income $76.8K narrower — against Q1 FY2025
Read the filingRegistration statement for an offering of securities
Read the filingRegistration statement for an offering of securities
Read the filingSigned a material agreement
Read the filingHad a director or senior officer leave or join
Read the filingAnnual report for FY2024
Revenue -39.2% · Operating margin −150.6 pts · Gross profit -82.8% — against FY2023
Read the filingAnnual report for FY2024
Revenue -39.2% · Operating margin −150.6 pts · Gross profit -82.8% — against FY2023
Read the filingTotaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
Yahoo Finance ·
Primary sources and further research